Development of step-specific PET tracers for studying fatty acid β- oxidation: Biodistribution of [1-11C] octanoate analogs in rats and a cat

Nuclear Medicine and Biology

Volumn 25, Issue 6, 1998, Pages 543-548

  Kawashima, Hidefumi ^a   Kuge, Yuji ^a   Yajima, Kazuyoshi ^a   Miyake, Yoshihiro ^a   Hashimoto, Naoto ^a  

^a Institute for Biofunctional Research Co Inc   (Japan)

Author keywords

1 11C 2 decynoate; 1 11C 2 octynoate; 1 11C 3 (R,S) methyloctanoate; Biodistribution; Fatty acid oxidation; PET

Indexed keywords

2 DECYNOIC ACID C 11; 2 OCTYNOIC ACID C 11; 3 METHYLOCTANOIC ACID C 11; FATTY ACID; OCTANOIC ACID DERIVATIVE C 11; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAT; DRUG DISTRIBUTION; DRUG LIVER LEVEL; FATTY ACID OXIDATION; HEART; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; RAT; TISSUE DISTRIBUTION;

ANIMALS; CARBON RADIOISOTOPES; CATS; FATTY ACIDS; MALE; OCTANOIC ACIDS; OXIDATION-REDUCTION; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031848737     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(98)00027-4     Document Type: Article

References (25)

1. 11C]palmitic acid A novel PET imaging agent for cardiac fatty acid metabolism . J. Med. Chem. 37:1994;2481-2485.
2. 11C] betamethylheptadecanoic acid. J. Nucl. Med. 35:1994;496-503.
3. Fink G.D., Montgomery J.A., David F., Garneau M., Livni E., Elmaleh D., et al. Metabolism of β-methyl-heptadecanoic acid in the perfused rat heart and liver. J. Nucl. Med. 31:1990;1823-1830.
4. Goodman M.M., Kirsch G., Knapp F.F. Jr. Synthesis and evaluation of radioiodinated terminal p-iodophenyl-substituted α- and β-methyl-branched fatty acids. J. Med. Chem. 27:1984;390-397.
5. Ikeda Y., Okamura-Ikeda K., Tanaka K. Purification and characterization of short-chain, medium-chain, and long-chain acyl-CoA dehydrogenases from rat liver mitochondria. J. Biol. Chem. 260:1985;1311-1325.
6. 11C]hexanoate as a PET tracer of fatty acid metabolism. Ann. Nucl. Med. 9:1995;51-57.
7. 11C]-3-(R,S)-methyloctanoic acid as potential markers for PET studies of fatty acid metabolism. J. Label. Compd. Radiopharm. 39:1997;181-193.
8. 2H substitution, for in vivo studies of myocardium using PET. Nucl. Med. Biol. 21:1994;1053-1065.
9. Knapp F.F. Jr, Kropp J., Goodman M.M., Franken P., Reske S.N., Ambrose K.R., et al. The development of iodine-123-methyl-branched fatty acids and their applications in nuclear cardiology. Ann. Nucl. Med. 7:(suppl. II):1993;SII-1-SII-14.
10. Knapp F.F. Jr, Kropp J. Iodine-123-labelled fatty acids for myocardial single-photon emission tomography Current status and future perspectives . Eur. J. Nucl. Med. 22:1995;361-381.
11. Knapp F.F. Jr, Franken P., Kropp J. Cardiac SPECT with iodine-123-labeled fatty acids Evaluation of myocardial viability with BMIPP . J. Nucl. Med. 36:1995;1022-1030.
12. 11C]octanoate in rats Pharmacokinetic basis for its application as a radiopharmaceutical for studying brain fatty acid metabolism . Ann. Nucl. Med. 9:1995;137-142.
13. 11C]Octanoate as a potential PET tracer for studying glial functions PET evaluation in rats and cats . Nucl. Med. Biol. 23:1996;1009-1012.
14. 11C]heptadecanoic acid A new myocardial metabolic tracer for positron emission tomography . J. Nucl. Med. 23:1982;169-175.
15. Magata Y., Yamamura N., Kitano H., Saji H., Konishi J. A new conceptual radiopharmaceutical for liver diagnosis by positron emission tomography. J. Nucl. Med. 38:(suppl.):1997;179P.
16. 18F]Fluorooctanoic acid and its β-substituted derivatives as potential agents for cerebral fatty acid studies Synthesis and biodistribution . Nucl. Med. Biol. 21:1994;809-817.
17. Powell P.J., Thorpe C. 2-Octynoyl coenzyme A is a mechanism-based inhibitor of pig kidney medium-chain acyl coenzyme A dehydrogenase Isolation of the target peptide . Biochemistry. 27:1988;8022-8028.
18. Raaka B.M., Lowenstein J.M. Inhibition of fatty acid oxidation by 2-bromooctanoate. J. Biol. Chem. 254:1979;3303-3310.
19. Reichmann H., Maltese W.A., DeVivo D.C. Enzymes of fatty acid β-oxidation in developing brain. J. Nurochem. 51:1988;339-344.
20. Roe C.R., Millington D.S., Maltby D.A., Kinnebrew P. Recognition of medium-chain acyl-CoA dehydrogenase deficiency in asymptomatic siblings of children dying of sudden infant death or Reye-like syndromes. J. Pediatr. 108:1986;13-18.
21. 11C]labeled hexanoate in anesthetized cats by means of positron emission tomography. Ann. Nucl. Med. 10:1996;361-366.
22. Wienhard K., Dahlbom M., Eriksson L., Michel C., Bruckbauer T., Pietrzyk U., et al. The ECAT EXACT HR Performance of a new high resolution positron scanner . J. Comput. Assist. Tomogr. 18:1994;110-118.
23. 11C-Carboxylates . J. Nucl. Med. 14:1973;747-754.
24. 11C]octanoate as a PET tracer . Ann. Nucl. Med. 10:1996;395-399.
25. Zhou J-Z, Thorpe C. Edomondson D.E., MacCormick D.B. Flavins and Flavoproteins. 1987;173-176 Walter de Gruyter, Berlin, New York.